Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2019-10-16 | 2019-11-25 | 96650 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2021-01-29 | 2021-02-23 | 132724 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2021-03-05 | 2021-04-12 | 135167 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2021-04-09 | 2021-05-17 | 137257 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2021-04-30 | 2021-05-17 | 138349 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2021-12-17 | 2022-03-29 | 151345 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2022-03-11 | 2022-05-05 | 156540 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-02-16 | 2023-04-04 | 185042 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-04-06 | 2023-07-13 | 188982 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-05-26 | 2023-07-13 | 193230 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-06-09 | 2023-07-13 | 194564 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-09-01 | 2024-02-09 | 203542 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-09-22 | 2023-12-08 | 204993 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-11-10 | 2023-12-08 | 209926 |
APO-MELOXICAM | 1.5G | SUSPENSION | Actual shortage | 2024-02-02 | 2024-05-17 | 218379 |
APO-MELOXICAM | 1.5G | SUSPENSION | Actual shortage | 2024-04-12 | 2024-04-12 | 224987 |
APO-MELOXICAM | 1.5G | SUSPENSION | Actual shortage | 2024-04-26 | 2024-04-26 | 226348 |
APO-RIVASTIGMINE | 1.5MG | CAPSULE | Resolved | 2017-09-04 | 2019-10-15 | 20900 |
APO-BROMAZEPAM | 1.5MG | TABLET | Resolved | 2018-05-15 | 2018-08-28 | 49484 |
APO-PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2018-05-16 | 2018-10-12 | 49517 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4915 |
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
APO-DIPYRIDAMOLE | 75MG | TABLET | Discontinued | 2019-12-20 | 2019-12-21 | 101880 |
APO-FUROSEMIDE | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
APO-SOTALOL | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |